Showing all 11 results

  • Buy Lynparza (Olaparib) Online For Sale

    $5,053.65

    DISEASE INDICATIONS: Breast Cancer, Gynaecological Cancer

    MANUFACTURER: AstraZeneca AB

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Lynparza is a medication that inhibits PARP enzymes, which repair DNA, to treat ovarian, fallopian tube, or primary peritoneal cancer in adults who have undergone more than three chemotherapy treatments, and it promotes cancer cell death.

  • Buy Ninlaro (ixazomib) Online For Sale

    $5,713.05

    DISEASE INDICATIONS: Multiple Myeloma

    MANUFACTURER: Takeda Pharma A/S

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Therapeutic Goods Administration (TGA)

    Ninlaro (ixazomib) is an oral medication used to treat multiple myeloma in combination with other drugs by blocking proteasome activities to promote cancer cell death.

  • Buy Odomzo (sonidegib) Online For Sale

    $5,229.00

    DISEASE INDICATIONS: Skin Cancer

    MANUFACTURER: Sun Pharmaceutical Industries Europe B.V.

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Therapeutic Goods Administration (TGA)

    Odomzo (sonidegib) is a medication used to treat basal cell carcinoma (BCC) in patients who cannot undergo surgery or radiation, or whose disease has recurred following such treatment.

  • Buy Onivyde (irinotecan hydrochloride trihydrate) Online For Sale

    $990.15

    DISEASE INDICATIONS: Pancreatic Cancer

    MANUFACTURER: Baxalta Innovations GmbH

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Onivyde (irinotecan hydrochloride trihydrate) is an injectable medication used to treat metastatic adenocarcinoma of the pancreas. It works by inhibiting topoisomerase I, an enzyme necessary for DNA replication in cancer cells.

  • Buy Perjeta (Pertuzumab) Online For Sale

    $2,441.25

    DISEASE INDICATIONS: Breast Cancer

    MANUFACTURER: Roche Registration Limited

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Perjeta (Pertuzumab) is a monoclonal antibody medication used for treating specific types of breast cancer that overexpress the HER2 protein. It works by binding to the HER2 protein, preventing cancer cell growth and promoting cell death.

  • Buy Portrazza (necitumumab) Online For Sale

    $7,384.65

    DISEASE INDICATIONS: Lung Cancer

    MANUFACTURER: Eli Lilly Nederland B.V.

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Portrazza is a monoclonal antibody used with gemcitabine and cisplatin to treat metastatic squamous non-small cell lung cancer, indicating for use only for patients with squamous non-small cell lung cancer. It targets the EGFR protein and prevents cancer cells’ growth and promotes cell death.

  • Buy Rubraca (rucaparib) Online For Sale

    From $1,614.90

    DISEASE INDICATIONS: Gynaecological Cancer

    MANUFACTURER: Clovis Oncology, Inc.

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Rubraca (rucaparib) is an orally administered medication used for the treatment of advanced ovarian cancer and prostate cancer.

  • Buy Rydapt (midostaurin) Online For Sale

    $14,017.50

    DISEASE INDICATIONS: Leukemia

    MANUFACTURER: Novartis Europharm Limited

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Rydapt, also known as midostaurin, is used to treat patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

  • Buy Tagrisso (Osimertinib) Online For Sale

    $5,460.00

    DISEASE INDICATIONS: Lung Cancer

    MANUFACTURER: AstraZeneca AB

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Tagrisso is a medication used to treat non-small cell lung cancer with EGFR T790M mutation. It inhibits the activity of the EGFR protein, leading to cancer cell death.

  • Buy Tecentriq (Atezolizumab) Online For Sale

    $5,983.95

    DISEASE INDICATIONS: Urothelial Carcinoma, Breast Cancer, Lung Cancer

    MANUFACTURER: Roche Registration Limited

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Therapeutic Goods Administration (TGA)

    Medsafe (NZ)

    Tecentriq (Atezolizumab) is an immunotherapy drug used to treat advanced non-small cell lung cancer and urothelial carcinoma (bladder cancer). By blocking protein PD-L1, it helps the immune system attack and destroy cancer cells.

  • Buy Zejula (niraparib) Online For Sale

    From $4,789.05

    DISEASE INDICATIONS: Gynaecological Cancer

    MANUFACTURER: Tesaro UK Limited

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Zejula is an oral PARP inhibitor used for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers in adult patients. Its mechanism of action blocks the PARP enzyme, preventing cancer cells from repairing damaged DNA causing their death.